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Abstract
Background: Incessant tachycardia may result in left ventricular (LV) systolic dysfunction.
Little is known about the influence of atrioventricular tachycardia (AVRT) and atrioventricu-
lar nodal re-entrant tachycardia (AVNRT) on LV systolic and diastolic function. The aim of
the study was to assess LV systolic and diastolic function and factors affecting LV systolic and
diastolic performance in patients with AVRT and AVNRT.
Material: The study group included 90 patients (40 male, 50 female, mean age 40 – 12 years)
with symptomatic narrow-QRS tachycardia. After an invasive electrophysiology study (EPS)
had been performed, these were divided into two groups: one (AVNRT) of 25 patients with
AVNRT and the other (WPW) of 65 patients with AVRT. The control group consisted of
50 healthy volunteers (23 male, 27 female, mean age 39 – 13 years). In all three groups transtho-
racic echocardiography was performed in order to assess LV systolic and diastolic function.
Results: LV fractional shortening (FS) (WPW: 32 – 6%, AVNRT: 36 – 4%, p < 0.005) and
ejection fraction (EF) (WPW: 54 – 7%, AVNRT: 55 – 5%, p < 0.001) were significantly
decreased in the study groups compared to the control group (FS: 40 – 5%, EF: 62 – 4%).
FS was significantly increased in the AVNRT compared to the WPW patients (p < 0.005).
LV diastolic dysfunction was found in 20 (80%) of the AVNRT and 55 (83%) of the WPW
group and in none of the patients from the control group. A positive correlation was found
between diastolic dysfunction and the scale of recurrence of AVRT (R = 0.67, p < 0.05) and
AVNRT (R = 0.52, p < 0.05).
Conclusions: AVNRT and AVRT may lead to development of LV systolic and diastolic
dysfunction. LV diastolic dysfunction is related to the frequency of AVRT or AVNRT recur-
rence. (Cardiol J 2007; 14: 160166)
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Introduction
Incessant tachycardia may lead to the develop-
ment of dilated cardiomyopathy with enlargement
and deterioration of left ventricular (LV) systolic
function [14]. Although the influence of atrioven-
tricular tachycardia (AVRT) and atrioventricular
nodal re-entrant tachycardia (AVNRT) on LV systo-
lic and diastolic function has not been clearly de-
fined, it is known that low-frequency long-lasting
AVRT with slow retrograde conduction in some
patients with Wolff-Parkinson-White syndrome
(WPW) may produce tachyarrhythmic cardiomyop-
athy [5, 6]. The aim of the study was to assess LV
systolic and diastolic function and factors affecting
LV systolic and diastolic performance in patients
with AVRT and AVNRT.
Methods
In this study we conducted a prospective anal-
ysis of 90 patients (40 male, 50 female, mean age
40 – 12 years) selected from 158 subjects with
symptomatic narrow-QRS tachycardia resistant to
pharmacological treatment. These patients under-
went transthoracic echocardiography (TTE) fol-
lowed by invasive electrophysiology study (EPS)
and radiofrequency catheter ablation (RFCA) in our
division between March 1998 and December 2000.
The control group consisted of 50 healthy volun-
teers (23 male, 27 female, mean age 39 – 13 years)
selected from 79 subjects. The study population was
divided into two groups: the first, AVNRT, consist-
ed of patients with atrioventricular node dissocia-
tion and AVNRT induced during electrophysiology
study (EPS) and the second, WPW, of patients with
pre-excitation syndrome and AVRT stimulated dur-
ing EPS. Inclusion criteria for the study groups were
the presence of an accessory pathway (AP) or atrio-
ventricular node dissociation and AVRT or AVNRT
induction during EPS. Patients were excluded
from the study group if more than one AP was
present (7 patients) or AP and atrioventricular node
dissociation co-existed in the same subject (2 pa-
tients). The presence of concomitant diseases, such
as coronary artery disease (2 patients), myocarditis
(1 patient), hypertension (22 patients), hypothyreo-
sis (2 patients) or valve dysfunction (29 patients),
conduction disturbances other than WPW (LBBB
 1 patient), obesity (BMI ‡ 30  7 patients), drug
intake (5 patients) or a poor TTE image (14 patients)
were also defined as exclusion criteria in both study
and control groups.
Assessment of potential factors affecting LV
performance was based on data analysis of the his-
tories. To reduce error in the precise frequency of
occurrence and duration of AVRT or AVNRT, scales
were introduced for AVRT or AVNRT duration
(3  more than five years, 2  one to five years,
1  less than one year) and recurrence (3  at least
once a week, 2  at least once a month, 1  less
than once a month).
Transthoracic echocardiography
TTE was performed without any information
on the patient or clinical data, using ACUSON
128XP with a 2.53.5 MHz transducer. All meas-
urements were made according to established
standards [7]. Recordings were taken with the pa-
tients in the left lateral decubitus position. The
M-mode traces and Doppler signals were recorded
at a speed of 50 mm/s. An average of three consec-
utive cycles was calculated for each parameter.
Measurements of LV end-diastolic, end-systolic and
left atrial dimensions were made on M-mode traces
recorded from the parasternal long axis view. LV
end-diastolic and end-systolic volumes were acquired
from the apical four-chamber view. Both diameters
and volumes were adjusted for body surface area.
LV ejection fraction (EF) by the bi-plane Simpson
method and mass were also calculated. Doppler
parameters of mitral and right upper pulmonary vein
(RUPV) flow, reflecting LV filling, were obtained
from the apical four-chamber view with a sample
volume of 24 mm. Mitral flow measurements in-
cluded peak early transmitral filling velocity dur-
ing early diastole (E), peak transmitral atrial filling
velocity during late diastole (A), deceleration time
(DT  the time elapsed between peak E velocity
and the point where the extrapolation deceleration
slope of the E velocity crosses the zero baseline),
isovolumic relaxation time (IVRT  the time be-
tween the aortic valve closure and mitral valve
opening) and the duration of A wave (tA). Assess-
ment of RUPV flow involved measurement of systo-
lic (S), diastolic (D) and atrial reversal (AR) peak
velocities and duration of the AR (tAR) wave. The
ratio of E and A (E/A) and S and D (S/D) waves and
the difference between the duration of the AR and
A waves (DT) were calculated. Measurements of
mitral and RUPV flows enabled LV diastolic func-
tion to be assessed [8]:
 normal;
 slow isovolumic relaxation [IVRT > 92 ms
(< 30 years), IVRT > 100 ms (3050 years),
IVRT > 105 ms (> 50 years)];
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 slow early LV filling [E/A < 1 and DT > 220 ms
(< 50 years), E/A < 0.5 and DT > 280 (> 50 years),
S/D > 1.5 (< 50 years), S/D > 2.5 (> 50 years)];
 mitral flow pseudonormalisation (E/A > 1,
DT and IVRT normal adjusted for age and com-
plying with at least three of the following crite-
ria [911]: S < D, E < A and increase in A velocity
during Valsalva manoeuvre, AR ‡ 0.35 m/s,
DT = tAR-tA ‡ 20 ms);
 mitral flow restriction (E/A > 2, DT < 140 ms,
S/D < 0.5, AR > 0.35 m/s, DT > 30 ms).
In the study groups TTE was performed up to
24 hours before EPS and RFCA and in the control
group during recruitment to the study.
Reproducibility
All measurements were made by two inde-
pendent observers and repeated in 10 randomly
chosen patients at least one month from the base-
line TTE in order to assess intra- and inter-observer
variability calculated as the difference of two val-
ues and their arithmetical mean quotient. Intra- and
inter-observer variability was found as follows: for
LV diameters 1.7 – 2.9% and 3.3 – 2.1, LV volumes
3.5 – 3.2% and 7.7 – 2.8, fractional shortening (FS)
2.3 – 2.2% and 4.4 – 2.6, EF 4.5 – 3.1 and 6.3 –
– 3.4, mitral and RUPV flow velocities 2.6 – 2.8 and
1.3 – 2.5%, DT and IVRT 7.1 – 5.4 and 9.1 – 4.6%.
Electrophysiology study
and ablation procedure
EPS and RFCA were performed according to
a previously described procedure [12]. All anti-ar-
rhythmic drugs were discontinued at least three
half-lives before the study, except for amiodarone,
which was withdrawn two months before. EPS was
performed using quadripolar diagnostic electrodes
introduced under fluoroscopic guidance. Three of
the electrodes with a 0.5 cm interpolar distance
were introduced via the femoral veins into the right
atrial appendage (HRA), His bundle area and right
ventricle apex. A fourth quadripolar diagnostic elec-
trode recording unipolar and bipolar signals from the
coronary sinus was introduced via the right inter-
nal jugular vein. The electrode was positioned in
a standard location, identical for each patient, in or-
der to obtain reproducible measurements. The right
atrium and right ventricle were paced with impuls-
es generated by Biotronic (Quinton Electrophysi-
ology Corp., Seattle, WA, USA), recorded and dis-
played with the help of the 1993 Quinton EPAmp
electrophysiological monitoring system. Two stim-
ulation protocols were performed during the study:
 programmed stimulation of the HRA with
a train of basic stimuli, a subsequent single
stimulus and afterwards double extra stimuli
with a gradually (20-ms step) shortened cou-
pling interval;
 incremental pacing protocol. RFCA was per-
formed with the ablation catheter placed at the
site of earliest activation, using commercial
ablation electrodes (Daig, Cordis, Medtronic).
Radiofrequency energy was delivered at 40 W,
with temperature up to 60°C for 60 s. In cases of
left-sided AP the radiofrequency catheter was
placed in the left atrium using a previously de-
scribed technique of trans-septal puncture [13]. In
the presence of atrioventricular node dissociation
and AVNRT induction RFCA was performed from
the right atrium [14].
Statistical analysis
All values were expressed as mean – SD.
Parametric demographic data and LV systolic and
diastolic parameters were compared with a two-
tailed Students test for unpaired variables with
normal distribution and with the Mann-Whitney test
for variables without normal distribution. Non-par-
ametric variables were assessed with the c2 test.
Spearmans regression analysis was used to corre-
late potential factors affecting LV performance with
parameters of LV systolic and diastolic function.
P value < 0.05 was required to fulfil statistical sig-
nificance.
Results
Study and control group characteristics
After EPS 25 patients with atrioventricular
node dissociation and AVNRT (mean frequency
181.3 – 25.4/min) were included in the AVNRT
group: the typical (22 patients, 88%), the atypical
(2 patients, 8%) and the slow-slow type (1 patient, 4%).
A total of 65 (72.2%) patients with AP and AVRT
(mean frequency 183.2 – 25.4/min) were included
in the WPW group. During EPS a left-sided AP was
found in 37 (56.9%) patients and right-sided in
28 (43.1%). In 29 (44.6%) patients the AP was local-
ised within the intraventricular septum and in
36 (55.4%) within the left or right ventricular free wall.
Orthodromic AVRT was stimulated in 62 (95.4%) and
antidromic in 3 (4.6%) patients. The control group
consisted of 50 healthy volunteers (23 male, 27 female,
mean age 39 – 13 years). No difference was found in
relation to age, sex, BMI, body surface area or systo-
lic and diastolic blood pressure values. AVNRT was
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more frequent in women on the verge of statistical
analysis (Table 1). Diameters and volumes were pre-
sented as body surface area indices.
Left ventricular systolic parameters in
the study and control groups
The results of a comparison of LV systolic pa-
rameters between the study and control groups are
shown in Table 2. Statistically significant differenc-
es in LV end-systolic diameters and FS were found
between the AVNRT and WPW groups. In the WPW
group end-systolic diameter was significantly in-
creased and FS reduced compared to the AVNRT
group. LVEF and FS in patients from the AVNRT
group were reduced in comparison with the control
group. An EF below 55% was found in 11 patients.
In the WPW group a statistically significant increase
in end-systolic diameter and volume and a reduc-
tion in LV FS and EF and in intraventricular septal
thickening was observed. In the WPW group an EF
below 55% was found in 35 patients, including one
patient with tachyarrhythmic cardiomyopathy and
an EF of 27%. A left or right-sided localisation of
the AP had no influence on LVEF or FS. AP locali-
sation within or outside the intraventricular septum
had an impact on intraventricular septal thickening.
In the case of AP localisation within the intraven-
tricular septum the thickening of the intraventricu-
lar septum was increased compared to a free-wall
localisation and similar to the control group (50 –
– 14 vs. 40 – 13, p < 0.005). If the AP was situat-
ed within the free wall, the intraventricular septal
thickening was significantly decreased compared to
the control group (40 – 13 vs. 52 – 17, p < 0.001).
Diastolic function parameters in
the study and control groups
A comparison of LV diastolic function parame-
ters between the study and control groups is shown
in Table 3. In 5 (20%) of the AVNRT patients LV
diastolic dysfunction was not found, slow isovolu-
mic relaxation was observed in 6 (24%), slow early
LV filling in 9 (36%) and mitral flow pseudonormal-
isation in 5 (20%) patients. In 11 (17%) patients
from the WPW group there were no LV diastolic
function abnormalities. However, slow isovolumic
Table 1. Study and control group characteristics.
Parameter AVNRT (n = 25) WPW (n = 65) Control (n = 50) p* p** p***
Age 42–11 39–11 39–13 NS NS NS
Gender 7 M (28%) 33 M (50.8%) 23 M (46%) 0.053 NS NS
BSA [m2] 1.77–0.15 1.8–0.15 1.75–0.19 NS NS NS
SBP [mm Hg] 123–11 125–12 121–10 NS NS NS
DBP [mm Hg] 77–8 75–6 76–8 NS NS NS
*Comparison between AVNRT and WPW groups; **comparison between AVNRT and control groups; ***comparison between WPW and control
groups; BSA  body surface area; SBP  systolic blood pressure; DBP  diastolic blood pressure
Table 2. LV systolic function parameters in the study and control groups.
Parameter AVNRT (n = 25) WPW (n = 65) Control (n = 50) p* p** p***
HR [1/min] 74–9 74–17 71–7 NS NS NS
EDD [cm/m2] 2.66–0.22 2.63–0.26 2.70–0.30 NS NS NS
ESD [cm/m2] 1.62–0.38 1.79–0.24 1.65–0.24 0.05 NS 0.005
LAD [cm/m2] 1.91–0.26 1.88–0.35 1.98–0.25 NS NS NS
M [kg/m2] 108–24 100–24 106–33 NS NS NS
FS [%] 36–4 32–6 40–5 0.005 0.005 0.001
IVSTh [%] 46–16 44–14 52–17 NS NS 0.05
PWTh [%] 63–18 57–18 62–15 NS NS NS
EDV [ml/m2] 41–7 44–12 45–12 NS NS NS
ESV [ml/m2] 19–4 21–8 17–5 NS NS 0.005
EF [%] 55–5 54–7 62–4 NS 0.001 0.001
*Comparison between AVNRT and WPW groups; **comparison between AVNRT and control groups; ***comparison between WPW and control
groups; HR  heart rate; EDD  LV end-diastolic diameter; ESD  LV end-systolic diameter; LAD  left atrial end-diastolic diameter; M  LV mass;
FS  LV fraction shortening; IVSTh  intraventricular septal thickening; PWTh  LV posterior wall thickening; EDV  LV end-diastolic volume;
ESV  LV end-systolic volume; EF  LV ejection fraction
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relaxation was found in 19 (29.2%), slow early LV
filling in 24 (36.9%), mitral flow pseudonormalisa-
tion in 10 (15.4%) and restriction in 1 (1.5%) pa-
tient. There were no differences in type of LV di-
astolic dysfunction between the AVNRT and WPW
groups (p > 0.05). No LV diastolic function abnor-
mality was found in any subject from the control
group.
The relations between potential factors influ-
encing LV performance and systolic and diastolic
function parameters are presented in Tables 4 and 5.
The frequency of AVRT or AVNRT and the scale
of AVRT or AVNRT recurrence and history dura-
tion were similar in the two groups (p > 0.05). The
only factor affecting LVEF was the scale of recur-
rence of AVRT in the WPW group. However, the
patient with tachyarrhythmic cardiomyopathy and
an EF of 27% having been excluded from the ana-
lysis, no such correlation was found (R = 0.23,
p = 0.068) in the WPW group. No relation was ob-
served between the scale of AVNRT recurrence and
LV systolic function in the AVNRT group. The scale
of AVRT or AVNRT recurrence affected LV diasto-
lic function. This positive correlation was stronger
in the WPW group.
Discussion
Chronic supraventricular tachycardia produc-
es a dilated cardiomyopathy. After one week of pac-
ing at 400/min, the left atrium booster pump for the
LV is affected and congestive heart failure starts to
develop with moderate increases in left atrial pres-
sure and LV volumes. After 6 weeks of rapid
Table 3. LV diastolic function parameters in the study and control groups.
Parameter AVNRT (n = 25) WPW (n = 65) Control (n = 50) p* p** p***
E [cm/s] 69–17 74–19 88–15 NS 0.001 0.001
A [cm/s] 68–13 68–19 63–11 NS NS NS
E/A 1.09–0.41 1.15–0.34 1.42–0.3 NS 0.001 0.001
DT [ms] 8–39 9–27 23–18 NS 0.001 0.001
DT [ms] 223–34 217–37 175–24 NS 0.001 0.001
IVRT [ms] 104–15 104–14 82–12 NS 0.001 0.001
Ev [cm/s] 55–16 59–14 70–13 NS 0.001 0.001
Av [cm/s] 60–0.13 61–16 55–11 NS NS 0.05
E/Av 0.93–0.35 1.0–0.3 1.30–0.23 NS 0.001 0.001
S [cm/s] 58–11 59–12 59–8 NS NS NS
D [cm/s] 49–10 53–11 55–8 NS 0.01 NS
S/D 1.18–0.30 1.16–0.30 1.08–0.18 NS 0.05 NS
AR [cm/s] 27–7 27–8 14–12 NS 0.001 0.001
*Comparison between AVNRT and WPW group; **comparison between AVNRT and control group; ***comparison between WPW and control group;
E  early mitral filling velocity; A  atrial filling velocity of mitral flow; E/A  ratio of E to A; DT  deceleration time of E wave; IVRT  isovolumic
relaxation time; Ev  early mitral filling velocity during Valsalva manoeuvre; Av  atrial filling velocity of mitral flow during Valsalva manoeuvre;
E/Av  ratio of E to A during Valsalva manoeuvre; S  systolic velocity of right upper pulmonary vein flow; D  diastolic velocity of right upper
pulmonary vein flow; S/D  ratio of S to D; AR  atrial reversal of systolic velocity of right upper pulmonary vein flow; DT  difference in duration
of A and AR waves
Table 5. Factors affecting LV diastolic function in
patients from the AVNRT and WPW groups.
Parameter AVNRT WPW
 (n = 25)  (n = 65)
R p R p
Scale 0.52 0.01 0.67 0.001
Frequency 0.25 NS 0.07 NS
Duration 0.08 NS 0.09 NS
R  Spearmans correlation index; scale scale of occurrence
AVRT or AVNRT; frequency  frequency of AVRT or AVNRT;
duration  time from the first ever episode of AVRT or AVNRT
Table 4. Factors affecting LV systolic function in
patients from the AVNRT and WPW groups.
Parameter AVNRT WPW
 (n = 25)  (n = 65)
R p R p
Scale 0.29 NS 0.27 0.05
Frequency [1/min] 0.07 NS 0.19 NS
Duration [years] 0.14 NS 0.05 NS
R  Spearmans correlation index; scale  scale of occurrence
AVRT or AVNRT; frequency  frequency of AVRT or AVNRT; dura-
tion  time from the first ever episode of AVRT or AVNRT
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pacing severe congestive heart failure is usually
present with a marked increase in LV end-diastolic
pressure, volumes and stiffness. LV dilation is ac-
companied by wall thinning in the absence of sig-
nificant changes in cardiac weight. On the cellular
level, myocyte loss or elongation, myofibril mis-
alignment and disruption of the extracellular matrix
architecture are reported [24, 1517].
This study demonstrates that recurrent epi-
sodes of AVRT or AVNRT affect LV function, both
systolic and diastolic. The results of LV systolic
function analysis in patients with AVRT or
AVNRT show that LVEF, FS and also, in the WPW
group, LV end-systolic diameters differ significantly
from those of healthy subjects and are compatible
with other data [5, 6] (Table 2). In agreement with
the results of Fishberger et al. [18] but in contrast
to other studies [15, 19], no significant differenc-
es were found between the study and control groups
with regard to LV end-diastolic diameters. However,
the number of subjects and the duration of tachy-
cardia in our study differed from other studies and,
in addition, patients with concomitant diseases were
excluded.
The localisation of AP within the free wall re-
sulted in a reduction of intraventricular septal thick-
ening. The probable mechanism of this finding is LV
wall asynergy during systole as a consequence of
a resting pre-excitation, which was present in
54 (83.1%) of WPW patients. Where there was AP free-
wall localisation, intraventricular septal contraction
was delayed in relation to the free wall. Posterior
wall thickening was not decreased in the presence
of AP within the intraventricular septum, which
could be expected. However, the precise localisa-
tion of the AP within the anterior or posterior part
of the intraventricular septum has not been taken
into account.
The mechanism of LV systolic dysfunction
development in patients with WPW syndrome and
orthodromic AVRT and patients with AVNRT is prob-
ably similar and resembles the model of rapid atrial
stimulation suggested by Spinale et al. [3]. It was
shown that atrial stimulation 240/min for three weeks
does not affect myocardial blood flow in the first in-
stance. Deterioration of myocardial perfusion is the
result of the development of heart failure. Myocardial
perfusion may be different in patients with orthodro-
mic and antidromic AVRT. Helmer et al. proposed an
experimental model of regional LV stimulation and
impaired myocardial blood flow within the stimulated
myocardium, resulting in myocyte damage [16].
Such analysis was not carried out in our study as there
were only 3 (4.6%) patients with antidromic AVRT.
It was shown in the present study that recur-
rent AVRT or AVNRT lead to LV diastolic function
disturbances, mainly slow LV relaxation or slow
early LV filling. More advanced types of LV diastolic
dysfunction, such as mitral flow pseudonormalisation
or restriction, were observed in 20% of AVNRT
and 14% of WPW patients. Quantitative analysis
of LV diastolic function parameters revealed signif-
icant differences between the study and control
groups (Table 3). However, RUPV systolic veloci-
ties did not differ between the study and control
groups. RUPV systolic velocity is related to mean
left atrial pressure and LV end-diastolic pressure.
An increase in mean left atrial or LV end-diastolic
pressure will result in a reduction of RUPV systol-
ic velocity and therefore mean RUPV systolic ve-
locity in patients with all types of LV diastolic dys-
function may not differ between the study and con-
trol groups. Analysis of potential factors influencing
LV systolic function showed that only the scale of
AVRT recurrence affects LVEF (Table 4). The pa-
tient with tachyarrhythmic cardiomyopathy having
been excluded from the WPW group, this correla-
tion was no longer found. No factors influencing LV
systolic performance were found in the AVNRT
group. The scale of AVRT or AVNRT recurrence
was proved to affect LV diastolic function. This
positive correlation was more significant in the
WPW group, which might be the result of the
number of subjects. The scale of AVRT or AVNRT
recurrence reflects the duration of exposure to tach-
ycardia. The more frequent the episodes of AVRT
or AVNRT, the longer the total exposure to tachy-
cardia and the more advanced the LV diastolic dys-
function. No relation between frequency of AVRT
or AVNRT and LV systolic or diastolic dysfunction
was observed. Such correlations have been de-
scribed in other studies [14, 19, 20], although in
our study the AVRT or AVNRT frequency only
ranged from 160 to 200/min in 87% of patients.
Conclusions
Atrioventricular tachycardia and atrioventricu-
lar nodal re-entrant tachycardia may lead to devel-
opment of left ventricular systolic and diastolic dys-
function. Left ventricular diastolic dysfunction is
related to the frequency of recurrence of the atrio-
ventricular tachycardia or atrioventricular nodal re-
entrant tachycardia.
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